The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma.
Saved in:
| Title: | The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma. |
|---|---|
| Authors: | Jones K; Blood Cancer Research, University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.; Clinical Immunohaematology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Wockner L; Statistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Brennan RM; Cellular Immunology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Keane C; Blood Cancer Research, University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.; Clinical Immunohaematology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia., Chattopadhyay PK; ImmunoTechnology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Roederer M; ImmunoTechnology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Price DA; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Institute of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK., Cole DK; Institute of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK., Hassan B; Institute of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK., Beck K; Tissue Engineering and Reparative Dentistry, Cardiff University School of Dentistry, Cardiff, UK., Gottlieb D; Blood and Marrow Transplant Service, Westmead Hospital, Sydney, Australia., Ritchie DS; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia.; University of Melbourne, Melbourne, Australia., Seymour JF; University of Melbourne, Melbourne, Australia., Vari F; Blood Cancer Research, University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia., Crooks P; Blood Cancer Research, University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia., Burrows SR; Cellular Immunology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Gandhi MK; Blood Cancer Research, University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.; Clinical Immunohaematology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia. |
| Source: | Clinical and experimental immunology [Clin Exp Immunol] 2016 Feb; Vol. 183 (2), pp. 206-20. Date of Electronic Publication: 2015 Nov 13. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2249 (Electronic) Linking ISSN: 00099104 NLM ISO Abbreviation: Clin Exp Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2249 |
|---|---|
| DOI: | 10.1111/cei.12716 |
